GAN-CARD
-
Minnesota cardiology firm raises $2M to fix congenital heart defects
A Minnesota cardiology firm that develops transcatheter septal occluders to repair congenital heart defects in […]
-
NeoChord raises $5M, seeks $11M for mitral regurgitation treatment
The market for cardiac surgery devices was valued at $2 billion in 2010. That includes […]
-
Do you advise self-insured employers? You Can Help Us!
Take part in this survey and share some of the trends you are seeing among your clients across healthcare, including chronic conditions, behavioral health and navigation.
-
AtriCure expects FDA clearance of new cryoablation system next quarter
Cardiology medical device maker AtriCure (NASDAQ:ATRC) expects to receive U.S. regulatory clearance for a new […]
-
Hospitals, MedCity Influencers
On the other side of the heart stent: a cardiologist’s perspective
Doing nothing is the hardest thing in the world for a doctor to do. After […]
-
Cardiac medical device firm Sunshine Heart raises $5 million
CORRECTED Eden Prairie, Minnesota-based cardiac medical device firm Sunshine Heart has raised Australian $4.6 million […]
-
Cardiac device firm developing esophagus heat map moves to Cleveland
A medical device company focused on specific minimally invasive cardiac surgeries has moved from Boston […]
-
St. Jude Medical’s novel heart disease diagnostic tool cleared in Europe
St. Jude Medical (NYSE:STJ) announced Thursday that it has received European regulatory clearance for its […]
-
Cleveland Clinic heart valve startup gets $3 million investment
Heart valve replacement device maker ValveXchange, a Cleveland Clinic spinoff, has received a $3.5 million […]
-
The top healthcare innovations in 2012? Here are some nominees
Word has it that Cleveland Clinic is gathering nominees from its staff for the best […]
-
Trayt Health Seeks to Increase Access to Diagnoses and Treatments
CEO Malekeh Amini explains how Trayt Health can bridge the gap for patients seeking neurological care.
-
Devices & Diagnostics, MedCity Influencers
Heart failure drug-device combination to use Medtronic technology
A drug-device combination bankrolled by Medtronic Inc. (NYSE:MDT) and developed by Nile Therapeutics Inc. (NSDQ:NLTX) […]
-
Advanced cardiac imaging company gets $1 million Ohio loan
Noninvasive cardiac imaging company CardioInsight Technologies has added another $1 million ahead of an August […]
-
AtriCure sees big potential in ‘hybrid’ atrial fibrillation procedure
Cardiac medical device maker AtriCure (NASDAQ:ATRC) sees big opportunity in a new “hybrid” procedure that […]
-
Medtronic stent graft system safe and effective
CORRECTION: Due to inaccurate information provided, an earlier version of the story stated that the Valiant […]
-
Athersys reports positive results from early heart attack clinical trial
Athersys (NASDAQ:ATHX) reported that results from a phase 1 trial of its stem cell therapy […]
-
Juventas’ stem cell therapy shows promise in phase 1 study
A phase 1 clinical trial has shown that Juventas Therapeutics‘ regenerative medicine therapy provides clinical […]